chr17-35475075-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001363830.2(SLFN12L):āc.1687G>Cā(p.Glu563Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001363830.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLFN12L | NM_001363830.2 | c.1687G>C | p.Glu563Gln | missense_variant | 5/5 | ENST00000628453.4 | |
SLFN12L | NM_001195790.3 | c.1561G>C | p.Glu521Gln | missense_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLFN12L | ENST00000628453.4 | c.1687G>C | p.Glu563Gln | missense_variant | 5/5 | 5 | NM_001363830.2 | A2 | |
SLFN12L | ENST00000260908.13 | c.1561G>C | p.Glu521Gln | missense_variant | 4/4 | 5 | P2 | ||
SLFN12L | ENST00000587436.1 | n.395+3000G>C | intron_variant, non_coding_transcript_variant | 2 | |||||
SLFN12L | ENST00000590802.1 | n.152+3000G>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250518Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135660
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461758Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 727152
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 05, 2024 | The c.1615G>C (p.E539Q) alteration is located in exon 4 (coding exon 4) of the SLFN12L gene. This alteration results from a G to C substitution at nucleotide position 1615, causing the glutamic acid (E) at amino acid position 539 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at